FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

RemedyRepack Metoprolol Tartrate Injection Recall

Metoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc

RemedyRepack Inc. · Indiana, PA

Risk level
Class III
Reported by FDA
Nov 21, 2018
Recall ID
D-0245-2019
Check your lot numberHow we source this data

Summary

RemedyRepack recalled Metoprolol Tartrate Injection starting Oct 26, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0245-2019 on Nov 21, 2018. Reason: Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing. Status: Terminated.

Why it was recalled

Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.

Product description

Metoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJ 08902, NDC# 70518-0868-00

Lot numbers, UPCs & expiration codes

Lot #: A0A0253, Exp. 02/2019; Lot #: B0369427-112717, Exp. 08/2019

Where it was sold

1 vial was distributed to a medical facility in Mayville, NY.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0245-2019
Classification
Class III
Status
Terminated
Recall initiated
Oct 26, 2018
FDA report date
Nov 21, 2018
Quantity
1 vial
Recall type
Voluntary: Firm initiated
Recalling firm
RemedyRepack Inc.

Original FDA data

Every field from FDA enforcement report D-0245-2019, exactly as published.

Show all FDA fields
City
Indiana
State
PA
Status
Terminated
Country
United States
Event ID
81554
Address
625 Kolter Dr Ste 4
Code information
Lot #: A0A0253, Exp. 02/2019; Lot #: B0369427-112717, Exp. 08/2019
Postal code
15701-3571
Report date
Nov 21, 2018
Product type
Drugs
Recall number
D-0245-2019
Classification
Class III
Recalling firm
RemedyRepack Inc.
Product quantity
1 vial
Termination date
Feb 5, 2019
Reason for recall
Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJ 08902, NDC# 70518-0868-00
Distribution pattern
1 vial was distributed to a medical facility in Mayville, NY.
Recall initiation date
Oct 26, 2018
Initial firm notification
Letter
Center classification date
Nov 14, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0245-2019, published Nov 21, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls